Current Report Filing (8-k)
01 11월 2022 - 5:07AM
Edgar (US Regulatory)
false 0000062709 0000062709 2022-10-31 2022-10-31 0000062709 exch:XNYS 2022-10-31 2022-10-31 0000062709 exch:XCHI 2022-10-31 2022-10-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported) October 31, 2022
Marsh & McLennan Companies, Inc.
(Exact Name of Registrant as Specified in its Charter)
![LOGO](https://content.edgar-online.com/edgar_conv_img/2022/10/31/0001193125-22-273899_g417836g1028075746986.jpg)
|
|
|
|
|
Delaware |
|
1-5998 |
|
36-2668272 |
(State or Other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
1166 Avenue of the Americas, New York, NY |
|
10036 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code (212) 345-5000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
|
Trading symbol(s) |
|
Name of exchange on which registered |
Common Stock, par value $1.00 per share |
|
MMC |
|
New York Stock Exchange |
|
|
|
|
Chicago Stock Exchange |
|
|
|
|
London Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 |
Entry into a Material Definitive Agreement |
On October 31, 2022, Marsh & McLennan Companies, Inc. (the “Company”) closed its previously announced sale of $500 million aggregate principal amount of its 5.750% Senior Notes due 2032 (the “2032 Notes”) and $500 million aggregate principal amount of its 6.250% Senior Notes due 2052 (the “2052 Notes” and, together with the 2032 Notes, the “Notes”).
The Notes were registered under the Company’s effective shelf registration statement on Form S-3 (Registration No. 333-258194) under the Securities Act of 1933, as amended, as filed with the Securities and Exchange Commission on July 27, 2021 and were offered by means of the Company’s prospectus dated July 27, 2021, as supplemented by the prospectus supplement dated October 24, 2022.
The Notes were issued on October 31, 2022 pursuant to the Indenture dated July 15, 2011, by and between the Company and The Bank of New York Mellon, as trustee (the “Trustee”), filed as Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, as supplemented by the Fifteenth Supplemental Indenture (the “Supplemental Indenture”), dated as of October 31, 2022, by and between the Company and the Trustee, which is attached hereto as Exhibit 4.1 and is incorporated herein by reference.
The forms of the 2032 Notes and 2052 Notes are attached hereto as Exhibits 4.2 and 4.3, respectively, and are incorporated herein by reference.
The foregoing descriptions of the Supplemental Indenture and the Notes contained herein are summaries and are qualified in their entirety by the Supplemental Indenture and the forms of Notes attached hereto as Exhibits 4.1, 4.2 and 4.3, respectively.
A copy of the opinion of Davis Polk & Wardwell LLP, counsel to the Company, relating to the legality of the Notes is filed as Exhibit 5.1 hereto.
Item 9.01 |
Financial Statements and Exhibits |
(d) Exhibits
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
MARSH & McLENNAN COMPANIES, INC. |
|
|
By: |
|
/s/ Connor Kuratek |
Name: |
|
Connor Kuratek |
Title: |
|
Deputy General Counsel & Corporate Secretary |
Date: October 31, 2022
3
Marsh and McLennan Compa... (NYSE:MMC)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Marsh and McLennan Compa... (NYSE:MMC)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024